Yushi Murai

SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19

Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani et al. · Journal of Medical Virology · 2021 · 54 citations · Full text

Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure

Kentaro Nagaoka, Hitoshi Kawasuji, Yushi Murai et al. · Frontiers in Immunology · 2022 · 20 citations · Full text

Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5

Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani et al. · Microbiology Spectrum · 2023 · 16 citations · Full text

A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test

Yushi Murai, Hitoshi Kawasuji, Yusuke Takegoshi et al. · International Journal of Infectious Diseases · 2021 · 15 citations · Full text

Fever Episodes, Clinical Infectious Disease, Viral Diagnostics +13

Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19

Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani et al. · Scientific Reports · 2021 · 15 citations · Full text